Literature DB >> 16868651

The renal type H+/peptide symporter PEPT2: structure-affinity relationships.

A Biegel1, I Knütter, B Hartrodt, S Gebauer, S Theis, P Luckner, G Kottra, M Rastetter, K Zebisch, I Thondorf, H Daniel, K Neubert, M Brandsch.   

Abstract

The H(+)/peptide cotransporter PEPT2 is expressed in a variety of organs including kidney, lung, brain, mammary gland, and eye. PEPT2 substrates are di- and tripeptides as well as peptidomimetics, such as beta-lactam antibiotics. Due to the presence of PEPT2 at the bronchial epithelium, the aerosolic administration of peptide-like drugs might play a major role in future treatment of various pulmonary and systemic diseases. Moreover, PEPT2 has a significant influence on the in vivo disposition and half-life time of peptide-like drugs within the body, particularly in kidney and brain. PEPT2 is known to have similar but not identical structural requirements for substrate recognition and transport compared to PEPT1, its intestinal counterpart. In this review we compiled available affinity constants of 352 compounds, measured at different mammalian tissues and expression systems and compare the data whenever possible with those of PEPT1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868651     DOI: 10.1007/s00726-006-0331-0

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  31 in total

1.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

Authors:  Xiaoxi Lu; Ting Chan; Chenghao Xu; Ling Zhu; Qi Tony Zhou; Kade D Roberts; Hak-Kim Chan; Jian Li; Fanfan Zhou
Journal:  J Antimicrob Chemother       Date:  2015-10-22       Impact factor: 5.790

2.  hPEPT1 is responsible for uptake and transport of Gly-Sar in the human bronchial airway epithelial cell-line Calu-3.

Authors:  Helle Bach Søndergaard; Birger Brodin; Carsten Uhd Nielsen
Journal:  Pflugers Arch       Date:  2007-12-20       Impact factor: 3.657

Review 3.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

4.  Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

Authors:  Rajendra S Kadam; Sunil K Vooturi; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

5.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

6.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 7.  Bacterial peptide transporters: Messengers of nutrition to virulence.

Authors:  Preeti Garai; Kasturi Chandra; Dipshikha Chakravortty
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

Review 8.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

9.  pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling.

Authors:  Jooeun Lee; Ivan Tattoli; Kacper A Wojtal; Stephan R Vavricka; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

Review 10.  Review. The mammalian proton-coupled peptide cotransporter PepT1: sitting on the transporter-channel fence?

Authors:  David Meredith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.